Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0002047607-26-000002

Options or other derivatives

  • Chief Strategy Officer acquired 95,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Riley Jennifer Chief Strategy Officer 2026-02-26 Grant or award · Stock Option (Right to Buy) +95,000 95,000 D
Loading xslF345X05/form4-03022026_090329.xml…